CARLSBAD, Calif., May 2, 2022 /PRNewswire/ -- Ionis
Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that
management will conduct its 2022 virtual Annual Meeting of
Stockholders followed by a general corporate update on Thursday, June 2, 2022.
The agenda for the event is as follows:
- 5:00 p.m. – 5:15 p.m. ET (2:00
p.m. – 2:15 p.m. PT) – Virtual
Annual Meeting of Stockholders
- All stockholders of record at the close of business on
April 5, 2022 are invited to
participate in the virtual Annual Meeting webcast, which will be
broadcast live at
http://www.virtualshareholdermeeting.com/IONS2022.
- Stockholders of record will receive an official proxy card,
which contains important information, including a 16-digit control
number, required to log-in, vote and submit questions during the
Annual Meeting webcast.
- Proxy cards are mailed to stockholders from their brokerage
firm. Ionis does not provide proxy cards or have access to proxy
card information, including 16-digit control numbers.
- Stockholders should contact their brokerage firm at least 5
days in advance of the meeting for help obtaining a proxy card or
to locate their control number or for instructions to access the
Webcast.
- A help line will be available on the registration page for the
live Annual Meeting webcast for participants requiring technical
assistance in accessing or participating in the live event. There
will not be a replay of the live Annual Meeting.
- 5:30 p.m. – 6:30 p.m. ET (2:30
p.m. – 3:30 p.m. PT) – Virtual
corporate update presented by Brett P.
Monia, Ph.D., Ionis' chief executive officer
- All interested parties may access the corporate update webcast
live at https://ionispharma.com/investor-day-2022.
- During the live webcast, participants may submit questions
using the online webcast platform.
- An archived replay of the corporate update will be posted for a
limited time following the meeting at
https://ir.ionispharma.com/events-and-presentations/upcoming-events.
Further information, including links and materials, are
available on our website at
https://ir.ionispharma.com/events-and-presentations/upcoming-events.
About Ionis Pharmaceuticals
For more than 30 years,
Ionis has been the leader in RNA-targeted therapy, pioneering new
markets and changing standards of care with its novel antisense
technology. Ionis currently has three marketed medicines and a
premier late-stage pipeline highlighted by industry-leading
cardiovascular and neurological franchises. Our scientific
innovation began and continues with the knowledge that sick people
depend on us, which fuels our vision of becoming a leading, fully
integrated biotechnology company.
To learn more about Ionis visit www.ionispharma.com and
follow us on Twitter @ionispharma.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-host-2022-virtual-annual-meeting-of-stockholders-301536707.html
SOURCE Ionis Pharmaceuticals, Inc.